| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.29 | 0.07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |